Weighty Matters in HIV Treatment 2021
Grace McComsey
MD, FIDSA
Case Western Reserve University, United States
Biography
Grace McComsey, MD, FIDSA, is a board-certified physician with training in Adult and Pediatric Infectious Diseases. She is the Vice President of Research and Associate Chief Scientific Officer at University Hospitals Health System (UHHS), Cleveland, Ohio, and a Professor of Pediatrics and Medicine at Case Western Reserve University. She leads the Clinical Research Center at UH, the central infrastructure for clinical research that oversees the more than 3,000 research studies across UHHS. She is also the Chief of the Division of Infectious Diseases at Rainbow Babies and Children’s Hospital in Cleveland, Ohio.
Dr McComsey is an internationally known researcher in the field of HIV. She is the author of over 270 peer-reviewed publications in the area of metabolic and cardiovascular complications of HIV infection and its treatment. Dr. McComsey has served as principal investigator on more than 20 grants from the National Institute of Health (NIH), in addition to several Foundation and Industry grants. She is currently serving as principal investigator on five NIH grants, mainly focused around understanding the mechanism, prevention, and management of metabolic and cardiovascular comorbidities in adults and children living with HIV.
Dr. McComsey has received several awards as the result of her research and leadership, including a Research Award from the HIV Medical Association of the Infectious Diseases Society of America recognizing her work in HIV metabolic complications and the YWCA Women of Professional Excellence Award. She was also recently named “2020 Woman of Note” by Crain’s for her leadership of the COVID Research program. Dr McComsey has been voted regularly as Best Doctors in America and in Cleveland, America’s Top 1% Physicians, and Exceptional Women in Medicine.
RELATED MATERIALS
RELATED COURSES

CME Series | Metabolic Health in People Living with HIV: What a Clinician Needs to Know
What Will Set You Apart?
After following this educational series, participants will:
- Describe the most common metabolic complications in people living with HIV
- Discuss the potential causes of metabolic complications, including chronic infection, comorbidities, ARV drugs, and aging
- Explain the appropriate diagnostic tests to screen for and routinely monitor metabolic complications in people living with HIV
- Apply interventions to reduce the risk of metabolic complications, including lifestyle, metabolic drugs, and choice of ARVs
Is This Program for You?
The program is aimed at healthcare professionals actively involved in caring for people living with HIV.
What Will You Cover in This Module?
People living with HIV (PLWHIV) are at an increased risk of metabolic complications due to chronic infection, persistent inflammation, concomitant conditions, or antiretroviral treatment. This module provides an expert-led review of metabolic health in PLWHIV, etiology of complications, approaches to monitor, and interventions to reduce the risk of such complications.